A large clinical trial of a drug that might protect nursing home from a COVID outbreak is currently being tested, according to an article on The New York Times website. It’s not easy to do a trial in nursing homes. Residents cannot be expected to travel, so the trial must to come to them.
When a positive Covid test is reported, the trial team brings two vehicles to the facility — a moving truck carrying infusion chairs, poles for intravenous infusions, bedside tables, and privacy screens and an R.V. with an interior retrofitted as a mobile lab with infusion materials, a centrifuge, freezers and computers to transmit data.
The team can turn a large dining room into an infusion center.
The study is being undertaken at nursing homes and extended care facilities across the United States and will enroll 2,400 residents and staff. The effort hopes to enlist 500 facilities.
As of mid July, More than 6,500 nursing home residents have died in New Jersey alone, according to an article on the NJ.com website.
Read the full New York Times article.
Design Standards as Strategic Assets
Rising Violence is Exposing Gaps in Hospital Security
Murray County Medical Center Reports Data Security Incident
Probiotic Cleaning: A Complementary Strategy for Safer Hospital Floors
VITAS Healthcare Breaks Ground on New Inpatient Hospice Center in Florida